Most Recent
Federal Court to weigh in on genome editing patent

A South Korean biotech company has filed an appeal with the Federal Court after an Ashurst partner succeeded in opposing the company’s proposed patent for a genome editing technology.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Fisher & Paykel loses opposition to breathing apparatus patent

The Australian Patent Office has thrown out Fisher & Paykel Healthcare’s opposition to a patent for a gas supply apparatus used to treat respiratory conditions owned by California-based medical equipment manufacturer, ResMed.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Reckitt lozenge ads banned for good as case by Difflam maker ends

Consumer goods giant Reckitt Benckiser has been permanently barred from displaying select ads for its Strepfen throat lozenges, as the Federal Court dismissed proceedings filed by rival iNova Pharmaceuticals.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

‘I just don’t get it’: judge questions Sandoz cross claim in Lexapro patent case

A Federal Court judge has expressed her disbelief at a cross claim by generic drug maker Sandoz against Danish multinational H Lundbeck, as the court begins to weigh arguments over damages owed to Lundbeck in the long-running patent case over its blockbuster anti-depressant Lexapro.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Merck Sharp & Dohme, Wyeth gear up for trial over vaccine patents

Preparations for a December trial between Merck Sharp & Dohme Corporation and Wyeth over four patents for the pneumococcal disease vaccine are underway, and a panel of experts will feature prominently in the high-stakes hearing over the world’s best-selling vaccine.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sirtex must alert class if cash dips below $80M, judge rules

Shareholders in a class action against Sirtex have secured an order forcing the life sciences company to notify them of any plan that would see its $128 million in liquid assets drop below $80 million.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Judge shoots down Sirtex bid for class closure order

A judge has rejected an application by biotech company Sirtex Medical to limit a class action to shareholders who register as group members in the next month, saying a class-closure order could dramatically cut down on the size of the class.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

HarperCollins looks to put deep sleep therapy defamation case to bed

HarperCollins has asked the Federal Court to toss a defamation case brought against it by two psychiatrists at the centre of the deep sleep therapy scandal that rocked the medical world in the 1960s and 70s, saying too much time had passed since the scandal.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

IVF clinic sues rival for copying ‘chubby cheeks’ ad campaign

An IVF clinic that pioneered the use of artificial intelligence for embryo selection has sued a rival clinic for allegedly copying an advertising campaign featuring the slogan “more chubby cheeks”.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

IVF law discriminates against married woman with estranged husband, judge finds

A Victorian woman can undergo IVF treatment using donor sperm without the consent of her estranged husband, the Federal Court has ruled, finding a state law that forced her to get the OK from her spouse breached federal discrimination laws.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?